Vertex Ventures HC - aVenture Asset Manager Research
Location
San Francisco, CA, US
Founded
2014
Vertex Ventures HC is a global healthcare investment firm that focuses on biopharmaceuticals, medical devices, and digital health sectors. With approximately $400 million in assets under management, the firm typically invests in Series A, B, and C rounds, but also participates in later stages such as Series D and E. Vertex Ventures HC is part of the broader Vertex Holdings network, allowing it to leverage extensive resources and expertise in the healthcare industry.
Notable portfolio companies include Neumora Therapeutics, ElevateBio, and Obsidian Therapeutics, among others. The firm is led by key partners with significant industry experience, contributing to its robust investment philosophy centered on innovation and impactful healthcare solutions. Vertex Ventures HC offers unique value-add services such as strategic guidance, operational support, and access to a global network, enhancing the growth potential of its portfolio companies.
Vertex Ventures HC - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
